Life and times in biochemical toxicology

International Journal of Toxicology

Volumn 24, Issue 1, 2005, Pages 5-21

  Guengerich, F Peter ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Biochemical Mechanisms; Enzymology; Future of Toxicology; Metabolism; Reactive Intermediates

Indexed keywords

ANTIBIOTIC AGENT; COAL TAR; INDIRUBIN; INDUSTRIAL CHEMICAL; IVERMECTIN;

AIR POLLUTION; CARCINOGENICITY; DRUG METABOLISM; ENZYMOLOGY; GENOTOXICITY; HUMAN; NONHUMAN; PREDICTION; REVIEW; RISK ASSESSMENT; TOXICITY TESTING; TOXICOLOGY;

ANIMALS; BIOCHEMISTRY; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; PORTRAITS; TOXICOLOGY; XENOBIOTICS;

EID: 17044392310     PISSN: 10915818     EISSN: None     Source Type: Journal    
DOI: 10.1080/10915810590918670     Document Type: Review

References (153)

1. Ames, B. N., W. E. Durston. E. Yamasaki, and F. D. Lee. 1973. Carcinogens are mutagens: A simple test system combining liver homogenates for activation and bacteria for detection. Proc. Natl. Acad. Sci. U. S. A. 70:2281-2285.
2. Avery, O. T., C. M. Macleod, and M. McCarty. 1944. Studies on the chemical nature of the substance inducing transformation of pnuemococcal types. I. Induction of transformation by a desoxyribonucleic acid fraction isolated from pneumonococcus type III. J. Exp. Med. 79:137.
3. 1: The ultimate carcinogenic species. J. Am. Chem. Soc. 110:7929-7931.
4. Barbin, A., H. Brésil, A. Croisy, P. Jacquignon, C. Malaveille, R. Montesano, and H. Bartsch. 1975. Liver-microsome-mediated formation of alkylating agents from vinyl bromide and vinyl chloride. Biochem. Biophys. Res. Commun. 67:596-603.
5. Baumann, E. 1876. Über Sulfosäuren im Harn. Ber. Chem. 9:54-58.
6. Bell, J. 1876. Paraffin epitheliuma of the scrotum. Edinburgh Med. J. 22:135-137.
7. Bell-Parikh, L. C., and F. P. Guengerich. 1999. Kinetics of cytochrome P450 2E1-catalyzed oxidation of ethanol to acetic acid via acetaldehyde. J. Biol. Chem. 274:23833-23840.
8. Blount, W. P. 1961. Turkey "X" disease. J. Br. Turkey Fed. 9:52-58.
9. Borman, S. 2004. Nipping bad drugs in the bud. Chem. Eng. News 82:36-39.
10. Borzelleca, J. F. 2000. Profiles in toxicology - Paracelsus: Herald of modern toxicology. Toxicol. Sci. 53:2-4.
11. Borzelleca, J. F. 2001. The art, the science, and the seduction of toxicology: An evolutionary development. In Principles and Methods of Toxicology, 4th ed., ed. A. W. Hayes, 1-21, Philadelphia: Taylor & Francis.
12. Burka, L. T., F. P. Guengerich, R. J. Willard, and T. L. Macdonald. 1985. Mechanism of cytochrome P-450 catalysis. Mechanism of N-dealkylation and amine oxide deoxygenation. J. Am. Chem. Soc. 107:2549-2551,
13. Busby, W. F., and G. N. Wogan. 1984. Aflatoxins. In Chemical Carcinogens, ed. C. E. Searle, 945-1136, Washington, DC: American Chemical Society.
14. PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines. Proc. Natl. Acad. Sci. U. S. A. 86:7696-7700.
15. Cai, H., and F. P. Guengerich. 1999. Mechanism of aqueous decomposition of trichloroethylene oxide. J. Am. Chem. Soc. 121:11656-11663.
16. Calabrese, E. J., and L. A. Baldwin. 2003. The hormetic dose-response model is more common than the threshold model in toxicology. Toxicol. Sci. 71:246-250.
17. Carson, R. 1962. Silent Spring. Boston: Houghton Mifflin.
18. - and HIV-1 reverse transcriptase. J. Biol. Chem. 279:19217-19229.
19. Cohn, R. 1893. Über das Auftreten acetylirter Verbindungen nach Darreichung von Aldehyden. Z. Physiol. Chem. 17:274-310.
20. Cook, J. W., and C. G. M. deWorms. 1937. Glucosides related to carcinogenic hydrocarbons. J. Chem. Soc. 1825-1828.
21. Cook, J. W., C. L. Hewett, and I. Hieger. 1933. The isolation of a cancer-producing hydrocarbon from coal tar. Parts I, II, and III. J. Chem. Soc. 394-405.
22. Creech, J. L., Jr., and M. N. Johnson. 1974. Angiosarcoma of liver in the manufacture of polyvinyl chloride. J. Occup. Med. 16:150-151.
23. Dannan, G. A., and F. P. Guengerich. 1982. Immunochemical comparison and quantitation of microsomal flavin-containing monooxygenases in various hog, mouse, rat, rabbit, dog, and human tissues. Mol. Pharmacol. 22:787-794.
24. Distlerath, L. M., and F. P. Guengerich. 1987. Enzymology of human liver cytochromes P-450. In Mammalian Cytochromes P-450, vol. 1, ed. F. P. Guengerich, 133-198. Boca Raton, FL: CRC Press.
25. Distlerath, L. M., P. E. B. Reilly, M. V. Martin, G. G. Davis, G. R. Wilkinson, and F. P. Guengerich. 1985. Purification and characterization of the human liver cytochromes P-450 involved in debrisoquine 4-hydroxylation and phenacetin O-deethylation, two prototypes for genetic polymorphism in oxidative drug metabolism. J. Biol. Chem. 260:9057-9067.
26. Evans, D. C., A. P. Watt, D. A. Nicoll-Griffith, and T. A. Baillie. 2004. Drug-protein adducts: An industry perspective on minimizing the potential for drug bioactivation in drug discovery and development. Chem. Res. Toxicol. 17:3-16.
27. Fahl, W. E., C. R. Jefcoate, and C. B. Kasper. 1978. Characteristics of benzo(a)pyrene metabolism and cytochrome P-450 heterogeneity in rat liver nuclear envelope and comparison to microsomal membrane. J. Biol. Chem. 253:3106-3113.
28. Fieser, L. F., and V. Desreux. 1938. The synthesis of 2- and 6-substituted derivatives of 20-methylcholanthrene. J. Am. Chem. Soc. 60:2255-2262.
29. Frederick, C. B., J. B. Mays, D. M. Ziegler, F. P. Guengerich, and F. F. Kadlubar. 1982. Cytochrome P-450 and flavin-containing monooxygenase-catalyzed formation of the carcinogen N-hydroxy-2-aminofluorene, and its covalent binding to nuclear DNA. Cancer Res. 42:2671-2677.
30. Gillam, E. M. J., A. M. Aguinaldo, L. M. Notley, D. Kim, R. G. Mundkowski, A. Volkov, F. H. Arnold, P. Soucek, J. J. DeVoss, and F. P. Guengerich. 1999. Formation of indigo by recombinant mammalian cytochrome P450. Biochem. Biophys. Res. Commun. 265:469-472.
31. Gillam, E. M. J., and F. P. Guengerich. 2001. Exploiting the versatility of human cytochrome P450 enzymes: The promise of blue roses from biotechnology. IUBMB Life 52:1-7.
32. Gillam, E. M. J., L. M. Notley, H. Cai, J. J. DeVoss, and F. P. Guengerich. 2000. Oxidation of indole by cytochrome P450 enzymes, Biochemistry 39:13817-13824.
33. Gribble, G. W. 2004. Amazing organohalogens. Am. Scientist 92:342-349.
34. Guengerich, F. P. 1977. Separation and purification of multiple forms of microsomal cytochrome P-450. Activities of different forms of cytochrome P-450 towards several compounds of environmental interest. J. Biol. Chem. 252:3970-3979.
35. Guengerich, F. P. 1978. Separation and purification of multiple forms of microsomal cytochrome P-450. Partial characterization of three apparently homogeneous cytochromes P-450 prepared from livers of phenobarbital- and 3-methylcholanthrene-treated rats. J. Biol. Chem. 253:7931-7939.
36. 1. Biochem. Pharmacol. 28:2883-2890.
37. Guengerich, F. P. 1992. Roles of the vinyl chloride oxidation products 1-chlorooxirane and 2-chloroacetaldehyde in the in vitro formation of etheno adducts of nucleic acid bases. Chem. Res. Toxciol. 5:2-5.
38. Guengerich, F. P. 1997. Introduction and historical perspective. In Biotransformation, vol. 3, Comprehensive Toxicology, ed. F. P. Guengerich, 1-6. Oxford: Elsevier Science.
39. Guengerich, F. P. 1998. The environmental genome project: Functional analysis of polymorphisms. Environ. Health Perspect. 106:365-368.
40. Guengerich, F. P. 1999. The Vanderbilt University Center in Molecular Toxicology: The first thirty years. Drug Metab. Rev. 31:1-11.
41. Guengerich, F. P. 2000. Metabolism of chemical carcinogens. Carcinogenesis 21:345-351.
42. Guengerich, F. P. 2001. Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity. Chem. Res. Toxciol. 14:611-650.
43. Guengerich, F. P. 2002. Cytochrome P450 enzymes in the generation of commercial products. Nat. Rev. Drug Discov. 1:359-366.
44. Guengerich, F. P. 2004a. Cytochrome P450: What have we learned and what are the future issues? 2003 North American Region ISSX Scientific Achievement Award. Drug Metab. Rev. 36:159-197.
45. Guengerich, F. P. 2004b. Where is toxicology headed in the future? Drug Metab. Rev. 36:473-484.
46. Guengerich, F. P. 2005. Effects of carcinogen-bound DNA on DNA polymerases. Chem. Rev., In press.
47. 1 oxidation products with lysine. Chem. Res. Toxicol. 15:780-792.
48. 1 dialdehyde by rat and human aldo-keto reductases. Chem. Res. Toxicol. 14:727-737.
49. Guengerich, F. P., W. M. Crawford, Jr., and P. G. Watanabe. 1979a. Activation of vinyl chloride to covalently bound metabolites: Roles of 2-chloroethylene oxide and 2-chloroacetaldehyde. Biochemistry 18:5177-5182.
50. Guengerich, F. P., G. A. Dannan, S. T. Wright, M. V. Martin, and L. S. Kaminsky. 1982. Purification and characterization of liver microsomal cytochromes P-450: Electrophoretic, spectral, catalytic, and immunochemical properties and inducibility of eight isozymes isolated from rats treated with phenobarbital or β-naphthoflavone. Biochemistry 21:6019-6030.
51. 1 exo-8,9-epoxide and relevance to toxicity and detoxication. Drug Metab. Rev. 31:141-158.
52. Guengerich, F.P., D.-H. Kim, and M. Iwasaki. 1991. Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects. Chem. Res. Toxicol. 4:168-179.
53. Guengerich, F. P., and T. L. Macdonald. 1984. Chemical mechanisms of catalysis by cytochromes P-450: A unified view. Acct. Chem. Res. 17:9-16.
54. Guengerich, F. P., and T. L. Macdonald. 1990. Mechanisms of cytochrome P-450 catalysis. FASEB J. 4:2453-2459.
55. Guengerich, F. P., M. V. Martin, P. H. Beaune, P. Kremers, T. Wolff, and D. J. Waxman. 1986. Characterization of rat and human liver microsomal cytochrome P-450 forms involved in nifedipine oxidation, a prototype for genetic polymorphism in oxidative drug metabolism. J. Biol. Chem. 261:5051-5060.
56. Guengerich, F. P., P. S. Mason, W. T. Stott, T. R. Fox, and P. G. Watanabe. 1981. Roles of 2-haloethylene oxides and 2-haloacetaldehydes derived from vinyl bromide and vinyl chloride in irreversible binding to protein and DNA. Cancer Res. 41:4391-4398.
57. Guengerich, F. P., W. A. McCormick, and J. B. Wheeler. 2003. Analysis of the kinetic mechanism of haloalkane conjugation by mammalian theta class glutathione transferases. Chem. Res. Toxicol. 16:1493-1499.
58. Guengerich, F. P., G. P. Miller, I. H. Hanna, H. Sato, and M. V. Martin. 2002b. Oxidation of methoxyphenethylamines by cytochrome P450 2D6. Analysis of rate-limiting steps. J. Biol. Chem. 277:33711-33719.
59. 7-aminoguanoisne and derivatives. Chem. Res. Toxicol. 12:906-916.
60. Guengerich, F. P., and T. Shimada. 1991. Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. Chem. Res. Toxicol. 4:391-407.
61. Guengerich, F. P., J. L. Sorrells, S. Schmitt, J. A. Krauser, P. Aryal, and L. Meijer. 2004. Generation of new protein kinase inhibitors utilizing cytochrome P450 mutant enzymes for indigoid coupling. J. Med. Chem. 43:3236-3241.
62. 1 dialdehyde adduct formed from reaction with methylamine. Chem. Res. Toxicol. 15:793-798.
63. Guengerich, F. P., P. Wang, P. S. Mason, and M. B. Mitchell. 1979b. Rat and human liver microsomal epoxide hydratase. Immunological characterization of various forms of the enzyme. J. Biol. Chem. 254:12255-12259.
64. 36Cl]-labeled vinyl chloride in vivo and in vitro. Biochem. Pharmacol. 28:589-596.
65. Guengerich, F. P., C.-H. Yun, and T. L. Macdonald. 1996. Evidence for a one-electron oxidation mechanism in N-dealkylation of N,N-dialkylanilines by cytochrome P450 2B1. Kinetic hydrogen isotope effects, linear free energy relationships, comparisons with horseradish peroxidase, and studies with oxygen surrogates. J. Biol. Chem. 271:27321-27329.
66. Gygi, S. P., B. Rist, and R. Aebersold. 2000. Measuring gene expression by quantitative proteome analysis. Curr. Opin. Biotechnol. 11:396-401.
67. His, W. 1887. Über das Stoffwechselproduct des Pyridins. Arch. Exp. Pathol. Pharmakol. 22:253-260.
68. Hueper, W. C. 1942. Occupational Tumors and Allied Diseases. Springfield, IL: Thomas.
69. 7 atom. Proc. Natl. Acad. Sci. U. S. A. 89:8278-8282.
70. 1: Mechanistic studies. J. Am. Chem. Soc. 116:1603-1609.
71. Jaffe, M. 1874. Über das Verhalten des Nitrotoluols im thierischen Organismus. Ber. Chem. 7:1673-1679.
72. Jaffe, M. 1879. Über die nach Einführing von Brombenzol und Chlorbenzol im Organismus entstehenden schwefelthaltigen Säuren. Ber. Chem. 12:1092-1098.
73. 1 exo-8,9-epoxide with DNA: Kinetic analysis of covalent binding and DNA-induced hydrolysis. Proc. Natl. Acad. Sci. U. S. A. 94:6121-6125.
74. 1 exo-8,9-oxide and rearrangement of the dihydrodiol. J. Am. Chem. Soc. 118:8213-8220.
75. 1 8,9-exo-epoxide catalyzed by rat and human glutathione transferases: Estimation of kinetic parameters. Biochemistry 36:3056-3060.
76. Jollow, D. J., J. R. Mitchell, W. Z. Potter, D. C. Davis, J. R. Gillette, and B. B. Brodie. 1973. Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo. J. Pharmacol. Exp. Ther. 187:195-202.
77. Kadlubar, F. F., J. A. Miller, and E. C. Miller. 1976. Microsomal N-oxidation of the hepatocarcinogen N-methyl-4-aminoazobenzene and the reactivity of N-hydroxy-N-methyl-4-aminoazobenzene. Cancer Res. 36:1196-1206.
78. Keller, W. 1842. Über Verwandlung der Benzoesäure in Hippursäure. Ann. Chem. 43:108-111.
79. Kim, D., F. F. Kadlubar, C. H. Teitel, and F. P. Guengerich. 2004. Formation and reduction of aryl and heterocyclic nitroso compounds and significance in the flux of hydroxylamines. Chem. Res. Toxicol. 17:529-536.
80. Kwak, M. K., N. Wakabayashi, and T. W. Kensler. 2004. Chemoprevention through the Keap1-Nrf2 signaling pathway by phase 2 enzyme inducers. Mut. Res. 555:133-148.
81. Lacassagne, A. 1932. Apparition de cancers de la mamelle chez la souris male, soumise a des injections de folliculine. C. R. Acad. Sci. 195:630-632.
82. Liebler, D. C. 2002. Introduction to Proteomics. Tools for the New Biology. Totowa, NJ: Humana Press.
83. Liebler, D. C., and F. P. Guengerich. 1983. Olefin oxidation by cytochrome P-450: Evidence for group migration in catalytic intermediates formed with vinylidene chloride and trans-1-phenyl-1-butene. Biochemistry 22:5482-5489.
84. 6-Alkylguanine-DNA alkyltransferase has opposing effects in modulating the genotoxicity of dibromomethane and bromomethyl acetate. Chem. Res. Toxicol. 17:742-752.
85. -. Biochemistry 35:9840-9849.
86. Lu, F. C. 1996. Basic Toxicology. Fundamentals, Target Organs, and Risk Assessment, Washington, DC: Taylor & Francis.
87. Macdonald, T. L., K. Zirvi, L. T. Burka, P. Peyman, and F. P. Guengerich. 1982. Mechanism of cytochrome P-450 inhibition by cyclopropylamines. J. Am. Chem. Soc. 104:2050-2052.
88. Mahgoub, A., J. R. Idle, L. G. Dring, R. Lancaster, and R. L. Smith. 1977. Polymorphic hydroxylation of debrisoquine in man. Lancet ii:584-586.
89. Manouvriez, A. 1876. Maladies et hygiène des ouvriers: Travaillant a la fabrication des agglomérés de houille et de brai. Ann. Hygiene Publique 45:459-482.
90. Miller, E. C. 1951. Studies on the formation of protein-bound derivatives of 3,4-benzpyrene in the epidermal fraction of mouse skin. Cancer Res. 11:100-108.
91. Miller, E. C., U. Juhl, and J. A. Miller. 1966. Nucleic acid guanine: Reaction with the carcinogen N-acetoxy-2-acetyl-2-aminofluorene. Science 153:1125-1127.
92. Miller, E. C., and J. A. Miller. 1947. The presence and significance of bound amino azodyes in the livers of rats fed p-dimethylaminoazobenzene. Cancer Res. 7:468-480.
93. Miller, E. C. J. A. Miller, R. W. Sapp, and G. M. Weber. 1949. Studies on the protein-bound aminoazo dyes formed in vivo from 4-dimethylaminoazobenzene and its C-monomethyl derivatives. Cancer Res. 9:336-343.
94. Miller, J. A. 1970. Carcinogenesis by chemicals: An overview. G.H.A. Clowes Memorial Lecture. Cancer Res. 30:559-576.
95. Miller, J. A. 1994. Brief history of chemical carcinogenesis. Cancer Lett. 83:9-14.
96. Miller, R. E., and F. P. Guengerich. 1982. Oxidation of trichloroethylene by liver microsomal cytochrome P-450: Evidence for chlorine migration in a transition state not involving trichloroethylene oxide. Biochemistry 21:1090-1097.
97. Mitchell, J. R., D. J. Jollow, W. Z. Potter, D. C. Davis, J. R. Gillette, and B. B. Brodie. 1973a. Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism. J. Pharmacol. Exp. Ther. 187:185-194.
98. Mitchell, J. R., D. J. Jollow, W. Z. Potter, J. R. Gillette, and B. B. Brodie. 1973b. Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. J. Pharmacol. Exp. Ther. 187:211-217.
99. Mueller, G. C., and J. A. Miller. 1948. The metabolism of 4-dimethylaminoazobenzene by rat liver homogenates. J. Biol. Chem. 176:535-544.
100. Nebert, D. W., L. Jorge-Nebert, and E. S. Vesell. 2003. Pharmacogenomics and "Individualized Drug Therapy": High expectations and disappointing achievements. Am. J. Pharmacogenomics 3:361-370.
101. Nicholson, J. K., and I. D. Wilson. 2003. Understanding 'global' systems biology: Metabonomics and the continuum of metabolism. Nature 2:668-676.
102. Okazaki, O., M. Persmark, and F. P. Guengerich. 1993. N-Nitroso-N-methylvinylamine: Reaction of the epoxide with guanyl and adenyl moieties to yield adducts derived from both parts of the molecule. Chem. Res. Toxicol. 6:168-173.
103. 7-guanyl)ethyl]glutathione adduct in glutathione-mediated binding of 1,2-dibromoethane to DNA. Proc. Natl. Acad. Sci. U. S. A. 80:5266-5270.
104. Parikh, A., E. M. J. Gillam, and F. P. Guengerich. 1997. Drug metabolism by Escherichia coli expressing human cytochromes P450. Nat. Biotechnol. 15:784-788.
105. Poland, A., and E. Glover. 1979. An estimate of the maximum in vivo covalent binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin to rat liver protein, ribosomal RNA, and DNA. Cancer Res. 39:3341-3344.
106. Potter, W. Z., D. C. Davis, J. R. Mitchell, D. J. Jollow, J. R. Gillette, and B. B. Brodie. 1973. Acetaminophen-induced hepatic necrosis. III. Cytochrome P-450-mediated covalent binding in vitro. J. Pharmacol. Exp. Ther. 187:203-210.
107. Qiu, Y., L. Z. Benet, and A. L. Burlingame. 1998. Identification of the hepatic protein targets of reactive metabolites of acetaminophenin vivo in mice using two-dimensional gel electrophoresis and mass spectrometry. J. Biol. Chem. 273:17940-17953.
108. 1: A new metabolite. Chem. Res. Toxicol. 5:333-335.
109. 1 exo and endo epoxides by rat and human glutathione S-transferases. Chem. Res. Toxicol. 5:470-478.
110. Rannug, U., A. Sundvall, and C. Ramel. 1978. The mutagenic effect of 1,2-dichloroethane on Salmonella typhimurium. I. Activation through conjugation with glutathione in vitro. Chem.-Biol. Interact. 20:1-16.
111. Rehn, L., 1895. Über Blasentumoren bei Fuchsinarbeitern. Archiv. Clin. Chirgurie 50:588-600.
112. Reitz, R. H., A. Mendrala, and F. P. Guengerich. 1989. In vitro metabolism of methylene chloride in human and animal tissues: Use in physiologically-based pharmacokinetic models. Toxicol. Appl. Pharmacol. 97:230-246.
113. Roberts, S. A., V. F. Price, and D. J. Jollow. 1990. Acetaminophen structure-toxicity studies: In vivo covalent binding of a nonhepatotoxic analog, 3-hydroxyacetanilide. Toxicol. Appl. Pharmacol. 105:195-208.
114. Schultzen, O., and C. Gräbe. 1867, Über das Verhalten der aromatischen Säuren beim Durchgang durch den thiersichen Organismus. Arch. Anatomie Physiol. 166-172.
115. Scribner, J. D., J. A. Miller, and E. C. Miller. 1970. Nucleophilic substitution on carcinogenic N-acetoxy-N-arylacetamides. Cancer Res. 30:1570-1579.
116. Selikoff, I. J., E. C. Hammond, and J. Churg. 1968. Asbestos exposure, smoking, and neoplasia. J. Am. Med. Assoc. 204:106-112.
117. Shimada, T., E. M. J. Gillam, Y. Oda, F. Tsumura, T. R. Sutter, F. P. Guengerich, and K. Inoue. 1999. Metabolism of benzo[a]pyrene to trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene by recombinant human cytochrome P450 1B1 and purified liver epoxide hydrolase. Chem. Res. Toxicol. 12:623-629.
118. NF, the nifedipine oxidase, being the principal enzyme involved in the bioactivation of aflatoxins in human liver. Proc. Natl. Acad. Sci. U. S. A. 86:462-465.
119. Shimada, T., C. L. Hayes, H. Yamazaki, S. Amin, S. S. Hecht, F. P. Guengerich, and T. R. Sutter. 1996. Activation of chemically diverse procarcinogens by human cytochrome P450 1B1. Cancer Res. 56:2979-2984.
120. Shimada, T., M. Iwasaki, M. V. Martin, and F. P. Guengerich. 1989a. Human liver microsomal cytochrome P-450 enzymes involved in the bioactivation of procarcinogens delected by umu gene response in Salmonella typhimurium TA1535/pSK1002. Cancer Res. 49:3218-3228.
121. Shimada, T., M. V. Martin, D. Pruess-Schwartz, L. J. Marnett, and F. P. Guengerich. 1989b. Roles of individual human cytochrome P-450 enzymes in the bioactivation of benzo(a)pyrene, 7,8-dihydroxy-7,8-dihydrobenzo(a)pyrene, and other dihydrodiol derivatives of polycyclic aromatic hydrocarbons. Cancer Res. 49:6304-6312.
122. Shimada, T., K. S. Misono, and F. P. Guengerich. 1986. Human liver microsomal cytochrome P-450 mephenytoin 4-hydroxylase, a prototype of genetic polymorphism in oxidative drug metabolism. Purification and characterization of two similar forms involved in the reaction. J. Biol. Chem. 261:909-921.
123. Speirs, A. L. 1962. Thalidomide and congenital abnormalities. Lancet 1:303-305.
124. Streeter, A. J., S. M. Bjorge, D. B. Axworthy, S. D. Nelson, and T. A. Baillie. 1984. The microsomal metabolism and site of covalent binding to protein of 3′-hydroxyacetanilide, a nonhepatotoxic positional isomer of acetaminophen. Drug Metab. Dispos. 12:565-576.
125. Sun, M. 1984. EDB contamination kindles federal action. Science 223:464-466.
126. Thier, R., M. Müller, J. B. Taylor, S. E. Pemble, B. Ketterer, and F. P. Guengerich. 1995. Enhancement of bacterial mutagenicity of bifunctional alkylating agents by expression of mammalian glutathione S-transferase. Chem. Res. Toxciol. 8:465-472.
127. Thier, R., S. E. Pemble, J. B. Taylor, W. G. Humphreys, M. Persmark, B. Ketterer, and F. P. Guengerich. 1993. Expression of mammalian glutathione S-transferase 5-5 in Salmonella typhimurium TA1535 leads to base-pair mutations upon exposure to dihalomethanes. Proc. Natl. Acad. Sci. U. S. A. 90:8576-8580.
128. Toide, K., H. Yamazaki, R. Nagashima, K. Itoh, S. Iwano, Y. Takahashi, S. Watanabe, and T. Kamataki. 2003. Aryl hydrocarbon hydroxylase represents CYP1B1, and not CYP1A1, in human freshly isolated white cells: Trimodal distribution of Japanese population according to induction of CYP1B1 mRNA by environmental dioxins. Cancer Epidemiol. Biomarkers Prev. 12:219-222.
129. Turesky, R. J., A. Constable, J. Richoz, N. Vargu, J. Markovic, M. V. Martin, and F. P. Guengerich. 1998. Differences in activation of heterocyclic aromatic amines by rat and human liver microsomes and by rat and human cytochromes P450 1A2. Chem. Res. Toxicol. 11:925-936.
130. Umbenhauer, D. R., G. R. Lankas, T. R. Pippert, L. D. Wise, M. E. Cartwright, S. J. Hall, and C. M. Beare. 1997. Identification of a P-glycoprotein-deficient subpopulation in the CF-1 mouse strain using a restriction fragment length polymorphism. Toxicol. Appl. Pharmacol. 146:88-94.
131. 6-alkylguanine-DNA alkyltransferase activation of a series of bis-electrophiles to produce mutagens. Chem. Res. Toxicol. 17:972-982.
132. Vaught, J., and E. Bresnick. 1976. Binding of polycyclic hydrocarbons to nuclear components in vitro. Biochem. Biophys. Res. Commun. 69:587-591.
133. von Volkman, R. 1875. Beitrage zur Chirurgie: Anschliessend an einen Bericht über die Thatigkeit der chirurgischen Universitats-klinik zu Halle im Jahre 1875. Leipzig: Breitkopf und Hartel.
134. Wang, P., P. S. Mason, and F. P. Guengerich. 1980. Purification of human liver cytochrome P-450 and comparison to the enzyme isolated from rat liver. Arch. Biochem. Biophys. 199:206-219.
135. Wang, P., J. Meijer, and F. P. Guengerich. 1982. Purification of human liver cytosolic epoxide hydrolase and comparison to the microsomal enzyme. Biochemistry 21:5769-5776.
136. Wang, P. P., P. Beaune, L. S. Kaminsky, G. A. Dannan, F. F. Kadlubar, D. Larrey, and F. P. Guengerich. 1983. Purification and characterization of six cytochrome P-450 isozymes from human liver microsomes. Biochemistry 22:5375-5383.
137. Watson, J. D., and F. H. C. Crick. 1953. Genetical implications of the structure of deoxyribonucleic acid. Nature 171:964-967.
138. Weisburger, J. H., and G. M. Williams. 1984. Bioassay of carcinogens: In vitro and in vivo tests. In Chemical Carcinogens, 2nd ed., vol. 2, ed. C. E. Searle, 1323-1373. Washington, DC: American Chemical Society.
139. Widmark, E. 1939. Presence of cancer-producing substances in roasted food. Nature 143:984.
140. Williams, R. T. 1947. Detoxication mechanisms, 1st ed. New York: Wiley.
141. Williams, R. T. 1959. Detoxication mechanisms, 2nd ed. New York: Wiley.
142. Wolff, T., L. M. Distlerath, M. T. Worthington, J. D. Groopman, G. J. Hammons, F. F. Kadlubar, R. A. Prough, M. V. Martin, and F. P. Guengerich. 1985. Substrate specificity of human liver cytochrome P-450 debrisoquine 4-hydroxylase probed using immunochemical inhibition and chemical modeling. Cancer Res. 45:2116-2122.
143. Wood, A. W., W. Levin, A. Y. H. Lu, H. Yagi, O. Hernandez, D. M. Jerina, and A. H. Conney. 1976. Metabolism of benzo[a]pyrene and benzo[a]pyrene derivatives to mutagenic products by highly purified hepatic microsomal enzymes. J. Biol. Chem. 251:4882-4890.
144. Wu, Z., P. Aryal, O. Lozach, L. Meijer, and F. P. Guengerich. 2005. Biosynthesis of new indigoid inhibitors of protein kinases using recombinant cytochrome P450 2A6. Chem. Biodiversity 2:51-65.
145. Wuosmaa, A. M., and L. P. Hager. 1990. Methyl chloride transferase: A carbocation route for biosynthesis of halometabolites. Science 249:160-162.
146. Yamagiwa, K., and K. Ichikawa. 1915, Experimentelle Studie über die Pathogenese der Epithelialgeschwulste. Mitt. Med. Fak. Tokio 15:295-344.
147. Yamazaki, H., Y. Inui, C.-H. Yun, M. Mimura, F. P. Guengerich, and T. Shimada. 1992a. Cytochrome P450 2E1 and 2A6 enzymes as major catalysts for metabolic activation of N-nitrosodialkylamines and tobacco-related nitrosamines in human liver microsomes. Carcinogenesis 13:1789-1794.
148. Yamazaki, H., Y. Oda, Y. Funae, S. Imaoka, Y. Inui, F. P. Guengerich, and T. Shimada. 1992b. Participation of rat liver cytochrome P450 2E1 in thé activation of N-nitrosodimethylamine and N-diethylnitrosamine to products genotoxic in Salmonella typhimurium NM2009. Carcinogenesis 13:979-985.
149. Yoo, J. S. H., F. P. Guengerich, and C. S. Yang. 1988. Metabolism of N-nitrosodialkylamines by human liver microsomes. Cancer Res. 48:1499-1504.
150. Yoshioka, T., J. A. Krauser, and F. P. Guengerich. 2002a. Tetrachloroethylene oxide: Hydrolytic products and reactions with phosphate and lysine. Chem. Res.Toxicol. 15:1096-1105.
151. Yoshioka, T., J. A. Krauser, and F. P. Guengerich. 2002b. Microsomal oxidation of tribromoethylene and reactions of tribromoethylene epoxide. Chem. Res. Toxciol. 15:1414-1420.
152. Yun, C.-H., G. P. Miller, and F. P. Guengerich. 2000. Rate-determining steps in phenacetin oxidations by human cytochrome P450 1A2 and selected mutants. Biochemistry' 39:11319-11329.
153. Zampaglione, N., D. J. Jollow, J. R. Mitchell, B. Stripp, M. Hamrick, and J. R. Gillette. 1973. Role of detoxifying enzymes in bromobenzene-induced liver necrosis. J. Pharmacol. Exp. Ther. 187:218-227.